2017

  • Mander B.A.Zhu A.H.Lindquist J.R., Villeneuve S., Rao V., Lu B.Saletin J.M.Ancoli-Israel A., Jagust W. and Walker M.P. White matter structure in older adults moderates the benefit of sleep spindles on motor memory consolidation. Journal of Neuroscience. 2017. 3033-16. doi: https://doi.org/10.1523/JNEUROSCI.3033-16.2017. [abstract]
  • Boudjemeline M, Hopewell R, Rochon PL, Jolly D, Hammami I, Villeneuve S, Kostikov A. Highly efficient solid phase-supported radiosynthesis of [11 C]PiB using tC18 cartridge as a “3-in-1” production entity. J Labelled Comp Radiopharm. 2017. (Epub ahead of print). doi:10.1212/WNL.0000000000003585. [abstract]
  • Villeneuve S. Potential Utility of Practice Effects in Preventive Trials. The Journal of Prevention of Alzheimer’s Disease. 2017. 4(3):140-142. [pdf].
  • Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M; Alzheimer’s Disease Neuroimaging Initiative. Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load. Neurology. 2017. (Epub ahead of print). doi:10.1212/WNL.0000000000003585. [abstract]

2016

  • Seo SW, Ayakta N, Grinberg LT, Villeneuve S, Lehmann M, Reed B, DeCarli C, Miller BL, Rosen HJ, Boxer AL, O’Neil JP, Jin LW, Seeley WW, Jagust WJ, Rabinovici GD. Regional correlations between [11C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort. Neuroimage Clin. 2016 Nov 11;13:130-137. [abstractpdf].
  • Villeneuve S. If not tau pathology, then what is the cause of Suspected Non-Alzheimer disease Pathophysiology? JAMA Neural. 2016. 73(10):1177-1179. doi:10.1001/jamaneurol.2016.2842. [abstractpdf].
  • Fletcher E, Villeneuve S, Maillard P, Harvey D, Reed B, Jagust W, DeCarli C. β-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals. Neurobiol Aging. 2016 Apr;40:173-80. doi:10.1016/j.neurobiolaging.2016.01.133. Epub 2016 Feb 22. [abstract].

2015

  • Villeneuve S, Brisson D, & Gaudet D. Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality. Journal of Lipids. 2015;2015: Article ID 742408 [abstractpdf].
  • Villeneuve S*, Rabinovici G*, Cohn-Sheehy B, Madison C, Ayakta N, Ghosh PM, Madison C, La Joie R, Arthur-Bentil SK, Vogel J, Marks S, Lehmann M, Rosen H, Reed B, Olichney J, DeCarli C, Miller BL, Borys E, Grinberg LT, Jin LW, Seeley WW & Jagust W. Existing PIB Thresholds are Too High: Statistical and Pathological Examination. Brain 2015;138:2020-2033 [abstractpdf] * Indicates that the authors contributed equally to the work.
  • Villeneuve S Wirth M & La Joie R. Are AD-typical regions the convergence point of multiple pathologies? Front Aging Neurosci. 2015 doi: 10.3389/fnagi.2015.00042 [abstractpdf].
  • Villeneuve S & Jagust W. Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment. J Prev Alz Dis 2015;2:64-70.  [abstractpdf].
    • 2014

  • Villeneuve S, Reed B, Madison C, Wirth M, Kriger S, Marchant N, Mack W, Sanossian N, DeCarli C, Chui H, Weiner M. & Jagust W. Vascular risk and cerebral β-amyloid interact to reduce cortical thickness. Neurology 2014;83:1-8 [abstractpdf].
  • Villeneuve S, Brisson D. Marchant N & Gaudet D. The role of Apolipoprotein E in personalized medicine. Front Aging Neurosci. 2014 doi: 10.3389/fnagi.2014.00154 [abstractpdf].
  • Wirth M, Villeneuve S, La Joie R, Marks S. & Jagust W. Gene-Environment interactions: Lifetime cognitive activity, APOE genotype, and beta-amyloid burden. J Neurosci2014;34:8612-8617 [abstractpdf].
  • Wirth M, Haase C, Villeneuve S, Vogel J. & Jagust W. Neuroprotective Pathways: Lifestyle activity, brain pathology and cognition in cognitively normal older adults. Neurobiol Aging. 2014;35:1873-1882 [abstractpdf].
  • Villeneuve S, Reed B, Wirth M, Madison C, Haase C. Ayakta N., M. Mack W, Sanossian N., DeCarli C, Chui H, Weiner M. & Jagust W. Cortical thickness mediates the impact of β-amyloid on episodic memory. Neurology. 2014;82:761-762 [abstractpdf].
  • Reed B, Villeneuve S, Mack W, DeCarli C, Chui H, Jagust H, Serum Lipids and Cerebral Amyloidosis in Persons with Elevated Vascular Risk. JAMA Neurol., 2014;71:195-200 [abstractpdf].
    • 2013

  • Wirth M, Villeneuve S, Madisona C, Oh H, Rabinovici G. & Jagust W. Associations between Alzheimer’s disease biomarkers, neurodegeneration, and cognition in normal older people. JAMA Neurol., 2013;70:1512-1519 [abstractpdf].
  • Peters S, Villeneuve S & Belleville S. Predicting Progression to Dementia in Elderly Subjects with Mild Cognitive Impairment Using Both Cognitive and Neuroimaging Predictors. J Alzheimer Dis., 2013;38:307-318 [abstractpdf].
  • Chao LL, DeCarli C, Kriger S, Truran D, Zhang Y, Laxamana J, Villeneuve S, Jagust WJ, Sanossian N, Mack W, Chui HC & Weiner MW. Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI PLOSone, 2013, 8: e65175 [abstractpdf].
  • Villeneuve S, Pepin V, Gosselin N, Gagnon K. & Gagnon J-F. Response to: Influence of OSA on cognitive impairment in patients with COPD. CHEST, 2013;143:1512-1513 [abstractpdf] .
  • Oh H, Madison C, Villeneuve S, Markley C. & Jagust W. Association of gray matter atrophy with age, β-amyloid, and cognition in aging. Cerebral Cortex., 2013, Epub ahead of print. PMID: 23389995 [abstractpdf].
    • 2012

  • Villeneuve S, Pépin V, Rahayel S, Bertrand J-A, Delorimier M, Desjardins C, Rizk A, Parenteau S, Beaucage F, Joncas S, Monchi O. & Gagnon J-F. Mild cognitive impairment in moderate to severe chronic obstructive pulmonary disease. CHEST, 2012; 142:1516-1523 [abstractpdf].
  • Villeneuve S. & Belleville S. The nature of memory failure in mild cognitive impairment: examining association with neurobiological markers and effect of progression, Neurobiol Aging, 2012; 33:1967-1978 [abstractpdf]. 
    • 2011

  • Villeneuve S, Massoud F, Bocti C, Gauthier S. & Belleville S. The nature of episodic memory deficits in MCI with and without vascular burden, Neuropsychologia, 2011; 49:3027-3035 [abstract,pdf].
  • Hudon C, Villeneuve S. & Belleville S. The effect of semantic orientation at encoding on free recall performance in amnestic mild cognitive impairment and probable Alzheimer’s disease. J Clin Expe Neuropsychol, 2011; 33:631-638 
    [abstractpdf].

  • Villeneuve S, Postuma RB, Joncas S, Latreille V, Rodrigues-Brazete J, Desjardin C. & Gagnon J-F. The dementia Rating scale to detect mild cognitive impairment in Parkinson’s disease and idiopathic REM sleep behavior disorder, Dement Geriatr Cogn Disord, 2011; 31:210-217 [abstractpdf.
  • Ouellet C, Melançon L. & Villeneuve S. Symptômes neuropsychiatriques et interventions cognitives chez les personnes avec trouble cognitif léger. Revue québ. Psychol., 2011; 32:35-56 [abstract].
    • 2010 and earlier

  • Villeneuve S & Belleville S. Cognitive reserve and neuronal changes associated with agingPsychol Neuropsychiatr du Vieil., 2010; 8:133-140 [abstractpdf].
  • Belleville S, Villeneuve S, Peters F. & Protat S. Vascular burden, cognition and aging, Revue de neuropsychologie, 2010; 2 :1-8 [abstract].
  • Villeneuve S, Belleville S, Massoud F, Bocti C. & Gauthier S. Impact of vascular risk factors and diseases on cognition in persons with mild cognitive impairment, Dement Geriatr Cogn Disord, 2009; 27:375-381 [abstractpdf].
  • Belleville, S. & Villeneuve S. Aspects neuropsychologiques de la démence vasculaire. Actualités sur les démences : Aspects Cliniques et Neuropsychologiques, Édition Solal : mai 2006 [abstract].
    • _________________________________________________________________
      DISCLAIMER: The documents distributed here have been provided as a means to ensure timely dissemination of scholarly and technical work on a noncommercial basis. Copyright and all rights therein are maintained by the authors or by other copyright holders, notwithstanding that they have offered their works here electronically. It is understood that all persons copying this information will adhere to the terms and constraints invoked by each author’s copyright and or other publishers (as appropriate). These works may not be reposted without the explicit permission of the copyright holder.

      _________________________________________________________________